一期半与两期翻修全髋关节置换术治疗慢性假体周围感染:生存率、再感染与患者报告结局的比较
回顾性比较123髋(一期半翻修54髋、两期翻修69髋)慢性假体周围感染行全髋关节置换翻修的结果,一期半翻修末次随访无感染生存率94%高于两期83%(P=0.048),病态肥胖是再感染唯一独立危险因素,两组手术/内科结局无差异,HOOS-JR评分均显著改善。
要点
- 一期半翻修末次随访无感染生存率94% vs 两期83%(P=0.048)。
- 病态肥胖是两队列再感染的唯一独立危险因素。
- 两组手术/内科结局无差异(P=0.730),HOOS-JR均显著改善(P<0.001)。
核心结论
- 一期半翻修似为全髋关节置换术后假体周围感染可接受的治疗选择,感染清除不劣于两期翻修,作者认为关节外科医生应考虑该术式。
研究设计与样本
- 回顾连续系列的一期半翻修或计划两期翻修全髋关节置换术,共纳入123髋(一期半翻修n=54,两期翻修n=69),平均临床随访2.5年(最长8年)。
主要发现
- 末次随访无感染生存率一期半翻修94% vs 两期83%,一期半翻修高11%(P=0.048)。
- 病态肥胖是两队列再感染的唯一独立危险因素。
- 两组手术/内科结局无差异(P=0.730)。
- HOOS-JR评分两组均显著改善:一期半翻修差值44.3,两期翻修差值32.5(P<0.001)。
- 82%的一期半翻修患者无进行性股骨或髋臼透亮线;两期翻修患者中94%无股骨透亮线、90%无髋臼透亮线。
临床怎么用
- 作者认为一期半翻修可作为全髋关节置换术后假体周围感染的治疗选择,关节外科医生应考虑该术式。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Management of periprosthetic joint infection after total hip arthroplasty (THA) has traditionally consisted of a 2-stage approach. However, 1.5-stage exchange has garnered recent interest. We compared 1.5-stage to 2-stage exchange recipients. Specifically, we assessed (1) infection-free survivorship and risk factors for reinfection; (2) 2-year surgical/medical outcomes (eg, reoperations, readmissions); (3) Hip Disability and Osteoarthritis Outcome Scores for Joint Replacement (HOOS-JR); and (4) radiographic outcomes (ie, progressive radiolucent lines, subsidences, and failures). METHODS: We reviewed a consecutive series of 1.5-stage or planned 2-stage THAs. A total of 123 hips were included (1.5-stage: n = 54; 2-stage: n = 69) with mean clinical follow-up of 2.5 years (up to 8 years). Bivariate analyses assessed incidences of medical and surgical outcomes. Additionally, HOOS-JR scores and radiographs were evaluated. RESULTS: The 1.5-stage exchange had 11% greater infection-free survivorship at final follow-up compared to 2 stages (94% versus 83%, P = .048). Morbid obesity was the only independent risk factor demonstrating increased reinfection among both cohorts. No differences in surgical/medical outcomes were observed between groups (P = .730). HOOS-JR scores improved markedly for both cohorts (1.5-stage difference = 44.3, 2-stage difference = 32.5; P < .001). A total of 82% of 1.5-stage patients did not demonstrate progressive femoral or acetabular radiolucencies, while 94% of 2-stage recipients did not have femoral radiolucencies and 90% did not have acetabular radiolucencies. CONCLUSION: The 1.5-stage exchange appeared to be an acceptable treatment alternative for periprosthetic joint infections after THAs with noninferior infection eradication. Therefore, this procedure should be considered by joint surgeons for treatment of periprosthetic hip infections.
引用
- Nace J, Chen Z, Bains SS, et al. 1.5-Stage Versus 2-Stage Exchange Total Hip Arthroplasty for Chronic Periprosthetic Joint Infections: A Comparison of Survivorships, Reinfections, and Patient-Reported Outcomes. J Arthroplasty. 2023. PMID: 36878441. doi:10.1016/j.arth.2023.02.072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。